Client Alert – Twenty States File Suit against Generic Drug Makers-Companies Accused of Collusion and Price-Fixing

On December 14, 2016, we shared the news that two former Heritage Pharmaceuticals (Heritage) executives had been charged by the U.S. Department of Justice in a generic drug pricing-fixing scheme—noting that the investigation was ongoing at both the state and federal levels and could touch dozens of other companies. That statement appears to be prescient, [...]